The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy.

The Percutaneous Cholecystostomy is Appropriate as the Ultimate Treatment of Acute Cholecystitis in Critically Ill Patients: a Cross-sectional Study at Single Center.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01894321

Enrollment

Registered

2013-07-10

Start date

2007-01-31

Completion date

2012-12-31

Last updated

2013-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Acalculous Cholecystitis, Acute Calculous Cholecystitis

Keywords

Acute cholecystitis, Elderly, Critically ill patients, Surgical high risk, Percutaneous cholecystostomy, Cholecystectomy

Brief summary

Percutaneous cholecystostomy (PC) is an effective treatment for cholecystitis in surgical high risk patients. However, there has been no definite agreement of the additional cholecystectomy in these patients. The investigators surveyed the clinical outcomes of the PC in surgical high risk patients. And the investigators tried to prove the PC can be appropriate and ultimate treatment for acute cholecystitis patients with critical illness through this study.

Detailed description

Between 2007 and 2012, all patients admitted for acute cholecystitis, and then underwent ultrasonography guided percutaneous cholecystostomy in Cheju Halla General Hospital were consecutively enrolled. Among 82 patients, 35 were performed laparoscopic cholecystectomy after recovery (Cholecystectomy group) and 47 treated by best supportive care without additional surgery (BSC group). The investigators analyzed their surgical risks and clinical outcomes of both patients retrospectively.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of acute cholecystitis * Underwent the ultrasound-guided percutaneous cholecystostomy

Exclusion criteria

* Transferred patients from other institute after cholecystostomy procedure.

Design outcomes

Primary

Measure	Time frame
All cause mortality	within 30 days

Secondary

Measure	Time frame	Description
Evidence of recurrent cholecystitis or biliary complication	Within 30 days	Acute cholecysitits : fever, abdominal pain, abnormal chemistry results Biliary complication : Gallstone pancreatitis, gallstone ileus or cholangitis

Countries

South Korea

Outcome results